Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavaila...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-05-01
|
| Series: | Asian Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087620303494 |
| _version_ | 1818656331963301888 |
|---|---|
| author | Fangmin Chen Yifan Fang Xiang Chen Rui Deng Yongjie Zhang Jingwei Shao |
| author_facet | Fangmin Chen Yifan Fang Xiang Chen Rui Deng Yongjie Zhang Jingwei Shao |
| author_sort | Fangmin Chen |
| collection | DOAJ |
| description | Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavailability, restricting its further clinical application. Over the past decade, with substantial progress achieved in the development of nanotechnology, various types of smart sorafenib nanoformulations have been developed to improve the targetability as well as the bioavailability of sorafenib. In this review, we summarize various aspects from the preparation and characterization to the evaluation of antitumor efficacy of numerous stimuli-responsive sorafenib nanodelivery systems, particularly with emphasis on their mechanism of drug release and tumor microenvironment response. In addition, this review makes great effort to summarize the nanosystem-based combination therapy of sorafenib with other antitumor agents, which can provide detailed information for further synergistic cancer therapy. In the final section of this review, we also provide a detailed discussion of future challenges and prospects of designing and developing ideal sorafenib nanoformulations for clinical cancer therapy. |
| first_indexed | 2024-12-17T03:23:54Z |
| format | Article |
| id | doaj.art-4704dceaf1e24d7c95909f6f6ae7ab01 |
| institution | Directory Open Access Journal |
| issn | 1818-0876 |
| language | English |
| last_indexed | 2024-12-17T03:23:54Z |
| publishDate | 2021-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Pharmaceutical Sciences |
| spelling | doaj.art-4704dceaf1e24d7c95909f6f6ae7ab012022-12-21T22:05:27ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762021-05-01163318336Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapyFangmin Chen0Yifan Fang1Xiang Chen2Rui Deng3Yongjie Zhang4Jingwei Shao5Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350116, ChinaFujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350116, ChinaFujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350116, ChinaFujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350116, ChinaFujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350116, ChinaFujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, College of Chemistry, Fuzhou University, Fuzhou, Fujian 350116, China; Institute of Oceanography, Minjiang University, Fuzhou 350108, China; Corresponding author.Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavailability, restricting its further clinical application. Over the past decade, with substantial progress achieved in the development of nanotechnology, various types of smart sorafenib nanoformulations have been developed to improve the targetability as well as the bioavailability of sorafenib. In this review, we summarize various aspects from the preparation and characterization to the evaluation of antitumor efficacy of numerous stimuli-responsive sorafenib nanodelivery systems, particularly with emphasis on their mechanism of drug release and tumor microenvironment response. In addition, this review makes great effort to summarize the nanosystem-based combination therapy of sorafenib with other antitumor agents, which can provide detailed information for further synergistic cancer therapy. In the final section of this review, we also provide a detailed discussion of future challenges and prospects of designing and developing ideal sorafenib nanoformulations for clinical cancer therapy.http://www.sciencedirect.com/science/article/pii/S1818087620303494SorafenibMulti-kinase inhibitorSmart nanodelivery systemsTumor microenvironmentCombination therapy |
| spellingShingle | Fangmin Chen Yifan Fang Xiang Chen Rui Deng Yongjie Zhang Jingwei Shao Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy Asian Journal of Pharmaceutical Sciences Sorafenib Multi-kinase inhibitor Smart nanodelivery systems Tumor microenvironment Combination therapy |
| title | Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy |
| title_full | Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy |
| title_fullStr | Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy |
| title_full_unstemmed | Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy |
| title_short | Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy |
| title_sort | recent advances of sorafenib nanoformulations for cancer therapy smart nanosystem and combination therapy |
| topic | Sorafenib Multi-kinase inhibitor Smart nanodelivery systems Tumor microenvironment Combination therapy |
| url | http://www.sciencedirect.com/science/article/pii/S1818087620303494 |
| work_keys_str_mv | AT fangminchen recentadvancesofsorafenibnanoformulationsforcancertherapysmartnanosystemandcombinationtherapy AT yifanfang recentadvancesofsorafenibnanoformulationsforcancertherapysmartnanosystemandcombinationtherapy AT xiangchen recentadvancesofsorafenibnanoformulationsforcancertherapysmartnanosystemandcombinationtherapy AT ruideng recentadvancesofsorafenibnanoformulationsforcancertherapysmartnanosystemandcombinationtherapy AT yongjiezhang recentadvancesofsorafenibnanoformulationsforcancertherapysmartnanosystemandcombinationtherapy AT jingweishao recentadvancesofsorafenibnanoformulationsforcancertherapysmartnanosystemandcombinationtherapy |